What Statins Did To My Muscles (Randomized Controlled Study)
In a Nutshell
A Harvard-trained doctor ran a blinded N=1 crossover trial on high-dose atorvastatin (80mg) vs. placebo, experiencing severe leg pain, fatigue, and impaired workout performance (e.g., declining ski erg sprints) after 10 days on the statin, while improving on placebo. Statins may impair muscles via mitochondrial dysfunction, CoQ10 depletion, and fat fuel restriction, challenging their "innocent until proven guilty" status amid weak human evidence. The experiment doubled as a social proof: personal N=1 stories outperform dry RCTs in sparking debate and views on statin risks.
These notes were generated by AI and may contain inaccuracies.
This little white pill is one of the most prescribed drugs in the world. This specific statin has generated over 150 billion dollars in sales and remains the frontline treatment for cardiovascular disease. It's often hailed as God's gift to medicine. After 4 years at Harvard Medical School and 6.5 years as a patient with high cholesterol, statins come with heavy baggage. Beyond the well-known muscle pain, myalgias, recent studies suggest a troubling link between statin use and age-related muscle loss.
Enter controversy. We've covered data on statins and muscle loss before on this channel. They're interesting, but still observational and can't prove causation. After that post, flooded with comments from people saying statins annihilated their workouts. Decided to close the knowledge gap using my own body. Ran a blinded crossover experiment taking high-dose statin versus placebo to find out what would happen to my body. If you think you know where this video is going, you don't.
It's the most profitable drug of all times. It's a gorilla dose. I'm gassed. Did statins impair my performance? Hey, what's going on, man? People deserve to know.
Video broken down into four chapters:
- Design of the study, methods, and self-experiment.
- Results: Did statins impact performance, and if so, how.
- Mechanisms: Possible biological explanations for how statins could affect muscle physiology and performance.
- Reveal: Behind-the-scenes twist about something else actually testing, but you need to earn that first.
More details at the associated Stay Curious Metabolism newsletter where data drops first.
Blinded crossover design: Completed both a placebo phase and statin phase, each intended to last 3 weeks, with a 3-week washout period in between. In practice, each phase ended up being 10 days with a 3-week washout. Reason: Previously taken statins and know how long for biological measurable effect, specifically reduction in LDL cholesterol as proxy for other effects.
Statin used: Atorvastatin 80 mg (brand Lipitor), most commonly prescribed statin, 80 mg highest dose, a gorilla dose. This specific statin ranked as most profitable drug of all time, generating over $150 billion for Pfizer as of 2017 (more now).
Randomization and Blinding
Randomization not simple. Hard to source placebo pill correct shape and size as the statin. Found 16 mm white oval placebo tablet closely mimicking 80 mg atorvastatin (which was 18 mm with engraving). Used cheese grater to remove engraving on statin and created mirrored mock mark on placebo. Mixed them with normal morning supplements in a pill box, swallowed all in one go even without water. Third party labeled one set A and one set B, kept randomization code until end of trial. Best effort at blinding.
Annoyed that voluntary N=1 placebo trials aren't easier. Once asked doctor about assigning placebo and statin; they said we don't do that. Patients should be allowed to run placebo trials on themselves with professional support.
Stress Test Protocol
Continued normal exercise routine: 1 hour of calisthenics per day throughout run-in (2 weeks before start), both phases A and B, and washout. During intervention phases A and B, tracked primary outcome: performance on Concept2 vertical ski erg machine.
Protocol: Five sets of 500 meter full-out sprints with 2-minute breaks between. Pace on the fifth set recorded as primary performance metric. Format balances explosivity and endurance. Not done at baseline, leadup, or washout—only during statin and placebo phases.
During phase A, around day 6, began experiencing muscle pains mostly in legs. Worsened by day 8, along with noticeable fatigue. Tired after workouts, recovery impaired. Symptoms worsened.
Today is day eight of the first arm, and I'm gassed. I just finished a pretty routine workout, took a shower. I've been having these pains in my legs similar to when I had Crestor before and I'm even more fatigued. I usually don't feel that fatigued after workouts. Recovery is usually pretty good, but I just feel terrible. Might end up ending this phase early.
Terminated phase A after 10 days. Blinded, but symptoms strong enough, impairing quality of life.
All right, it's day 10 of phase A and I'm calling it. I'm just not feeling good. I've been having these leg pains, feeling pretty fatigued. So, I'm going to go into the wash out, then we'll go to phase B.
Possibility that if no symptoms in phase B, might not try as hard, confounding results. Nothing to protect against it, but symptoms feel real.
In addition to leg pain, felt more wiped out after workouts, as if recovery impaired. Reflected in performance, which declined around day 6. Subjectively, not pain-limited (pain in lower legs, upper body movement, high pain tolerance).
After 3-week washout, during phase B, opposite trend: performance improved after 6 days, felt great after workouts, motivated.
Notes Before Reveal
Endurance athlete by nature: Ran sub-3-hour marathons as teenager, PR 2:45 at age 17. Daily stress tests for 10 days not overwhelming under normal conditions.
Didn't measure lipids or creatine kinase (marker of muscle damage) to avoid unblinding. Safe to assume statin phase lowered LDL by 15-30% based on previous trials (see linked paper). In previous statin trials, had elevation in creatine kinase, suggesting susceptibility to muscle damage.
First Reveal
Statins did impair performance quite dramatically. Phase A was statin, phase B was placebo.
Take results for what they're worth. Results less interesting than potential mechanisms.
N=1 experiment, most relevant to me, would not assume generalizes. If accepting real negative impact, possible explanations:
- Direct inhibition of mitochondrial metabolism: Human studies show even at very low nanomolar concentrations, statins (particularly atorvastatin) inhibit key components of mitochondrial electron transport chain, including complex 4. Necessary for proton gradient powering ATP production via oxidative phosphorylation (endurance energy). Creates bottleneck.
- Reduction in co-enzyme Q10 in muscle cells and mitochondria: Electron carrier and antioxidant, vital to mitochondrial energy metabolism. Lower levels create choke point.
- Cells starved for fat fuel: Lean, insulin-sensitive, ketogenic—body runs on fats and ketones. Fat fuel in particles containing cholesterol (why cholesterol high; see linked letter). Lowering cholesterol via statins could restrict circulating fat fuel and energy flux. (Doesn't think this carries bulk of impairment; further commentary linked.)
More possibilities: Direct myotoxicity, muscle damage caused by statin, altered intramuscular calcium signaling, impaired tissue recovery.
Brainstorm other mechanisms in comments. All hypothesis-generating. Point is biological plausibility for real human clinical effect.
Actual purpose was something else measuring.
Mini-rant: Where to place burden of proof in science and medicine? Ongoing controversy about statins' real impact on muscle health. Human data beyond this aren't perfect or definitive.
When weighing long-term risks, should not assume no risk until proven without shadow of doubt. Pharmacology should not be innocent until proven guilty. If credible risk (including associational data, credible concern about long-term effects like muscle loss), take seriously rather than dismiss for lack of perfect data.
Powerful drugs should not be innocent until proven guilty.
Not claiming statins definitively cause muscle loss, function loss, or loss of muscle mass. Saying we haven't proven they don't. They might. Reason to believe they would. People deserve to know.
How to get people to know? Huge bias in medicine and media toward highlighting drug benefits, downplaying side effects—from training, incentives, dominant narratives, status quo inertia. Statins held as untouchable God's gift; otherwise, you're a denier. Without big pharma billions for ads.
What has: Social media credentials and creativity. Video not about performance data—it was a social experiment (done before).
Example: Paper review on dietary cholesterol not raising blood cholesterol, covering metabolism data and hormone chisin. Fine video, few views. Then made personal: 720 egg experiment. Same data in N=1 narrative. Exploded—hundreds of millions of views across platforms (even TikTok, media sources not on). Got flown around world to party with celebrities.
Hey, what's going on, man? This is your boy Acon. Just wanted to give a big shout out to my man Dr. Nick Noritz.
Reporters from several continents interviewed at apartment. Weirdly big in South Korea and India.
Repeated pattern, works every time. Stories through own experience get attention, spark curiosity, get people thinking.
Paradox: Say we want rigor, RCTs, peer-reviewed prestige. What spreads and convinces: stories, personal stories, human stories. How we learn, internalize, built by evolution as social species. Emotional learning drive powerful.
This whole thing: social experiment, proof of principle on what drives conversation, changes minds (including doctors').
Posted two videos:
- One covering 300,000-person study on statins and muscle loss.
- This one: Little N=1 experiment.
Data to see how they do, test hypothesis.
Stay curious. Let me know what you loved, hated, your thoughts. I love your feedback. They're data to me and that's the point.
Keep Nick Norwitz in your library
Save the videos and channels worth coming back to, and find them again in one place.
